Hemorrhage Countermeasure Evaluation Capabilities RFI
| Agency: | DEPT OF DEFENSE |
|---|---|
| State: | Federal |
| Type of Government: | Federal |
| FSC Category: |
|
| NAICS Category: |
|
| Posted Date: | Apr 15, 2026 |
| Due Date: | May 4, 2026 |
| Solicitation No: | DARPA-SN-26-61 |
| Original Source: | Please Login to View Page |
| Contact information: | Please Login to View Page |
| Bid Documents: | Please Login to View Page |
Description
Follow
Active
Contract Opportunity
Notice ID
DARPA-SN-26-61
Related Notice
Department/Ind. Agency
DEPT OF DEFENSE
Sub-tier
DEFENSE ADVANCED RESEARCH PROJECTS AGENCY (DARPA)
Office
DEF ADVANCED RESEARCH PROJECTS AGCY
General Information View Changes
Classification
Description
Contact Information
History
- Contract Opportunity Type: Special Notice (Updated)
- Updated Published Date: Apr 15, 2026 02:52 pm EDT
- Original Published Date: Apr 09, 2026 11:07 am EDT
- Updated Response Date: May 04, 2026 04:00 pm EDT
- Original Response Date: May 04, 2026 04:00 pm EDT
- Inactive Policy: Manual
- Updated Inactive Date: May 05, 2026
- Original Inactive Date: May 05, 2026
-
Initiative:
- None
- Original Set Aside:
- Product Service Code: AC12 - NATIONAL DEFENSE R&D SERVICES; DEPARTMENT OF DEFENSE - MILITARY; APPLIED RESEARCH
-
NAICS Code:
- 541714 - Research and Development in Biotechnology (except Nanobiotechnology)
-
Place of Performance:
The Biological Technologies Office (BTO) of the Defense Advanced Research Projects Agency
(DARPA) seeks input from industry and academia regarding capabilities for providing independent verification and validation, clinical trial, and commercialization support for hemorrhage countermeasures. This Request for Information (RFI) is a preliminary step to identify potential partners capable of providing third-party assessments of safety and efficacy of potential hemorrhage countermeasures and assisting in development strategies to ensure said products transition from the laboratory to civilian and government markets after research, development, testing, and evaluation (RDT&E) efforts have ended. DARPA is particularly interested in respondents who can address all the above task domains to allow one provider to have comprehensive knowledge about the data for efficiency and to tailor commercialization and regulatory strategies.
(DARPA) seeks input from industry and academia regarding capabilities for providing independent verification and validation, clinical trial, and commercialization support for hemorrhage countermeasures. This Request for Information (RFI) is a preliminary step to identify potential partners capable of providing third-party assessments of safety and efficacy of potential hemorrhage countermeasures and assisting in development strategies to ensure said products transition from the laboratory to civilian and government markets after research, development, testing, and evaluation (RDT&E) efforts have ended. DARPA is particularly interested in respondents who can address all the above task domains to allow one provider to have comprehensive knowledge about the data for efficiency and to tailor commercialization and regulatory strategies.
Attachments/Links
Contracting Office Address
- 675 NORTH RANDOLPH STREET
- ARLINGTON , VA 222032114
- USA
Primary Point of Contact
- Lt. Cmdr. Robert Murray, DARPA/BTO
- DARPA-SN-26-61@darpa.mil
Secondary Point of Contact
- Apr 15, 2026 02:52 pm EDTSpecial Notice (Updated)
- Apr 09, 2026 11:07 am EDT Special Notice (Original)
Related Document
| Apr 9, 2026 | [Special Notice (Original)] Hemorrhage Countermeasure Evaluation Capabilities RFI |
Get Government Bids Like This by Email
Receive daily bid alerts that match your keywords, business categories, and target regions.
See Also
Follow ARPA-H Comprehensive Organ System Modeling in Outer Space (COSMOS) Innovative Solutions Opening
HEALTH AND HUMAN SERVICES, DEPARTMENT OF
Due by 10/07/2026
Follow Biobanking, Laboratory Analytics, and Associated Informatics Services for NIH Biorepositories Active Contract
HEALTH AND HUMAN SERVICES, DEPARTMENT OF
Due by 10/20/2026
Follow RFI for Next Generation Hypersonic Cruise Missiles Active Contract Opportunity Notice ID
DEPT OF DEFENSE
Due by 11/06/2026
Follow N66001-26-R-0030 - Academic Research MAC Active Contract Opportunity Notice ID N6600126R0030 Related
DEPT OF DEFENSE
Due by 10/09/2026
* Disclaimer: This website provides information about bids, requests for proposals (RFPs), or requests for qualifications (RFQs) for convenience only and does not serve as an official public notice. Individuals who wish to respond to or inquire about bids, RFPs, or RFQs should contact the relevant government department directly.